세계 이식형 의료기기 시장 : 제품 유형, 최종 사용자별, 지역별 분석(-2030년)

According to Stratistics MRC, the Global Implantable Medical Devices Market is accounted for $124.8 billion in 2023 and is expected to reach $259.2 billion by 2030 growing at a CAGR of 11.0% during the forecast period. Medical implants are objects or tissues that are inserted beneath the skin or inside the body. The purpose of implants is to replace missing body parts with prostheses. The implants may be inserted permanently for therapeutic, diagnostic, or monitoring purposes, or they may be withdrawn after their function has been met. Implants are utilized in numerous sections of the body for a variety of purposes, including drug delivery systems, neural prosthetics, orthopedics, pacemakers, cardiovascular stents, and defibrillators. Implants are inserted into the human body either fully or partially through surgical or medicinal procedures. Health care benefits from implantable medical devices include increased patient safety and quality of life.

According to the WHO, in 2022, the US recorded 50 million epilepsy cases; 1 billion migraine cases; and 400,000 spinal cord injury cases.

Market Dynamics:

Driver:

Increasing focus on personal appearance

This method is becoming increasingly common in the workplace and during social gatherings that boost one's self-confidence and self-esteem. In order to improve one's beauty and physical appearance, aesthetic products like facial implants are being adopted more frequently. Additionally, facial implants are primarily used to enhance or correct the skeletal concavities and convexities of the face. Both genders are placing more emphasis on jaw correction since a well-defined jaw line is thought to accentuate a man's attractiveness, while an angular jaw line is preferred by women. As a result, these elements are having a beneficial effect on market expansion.

Restraint:

High cost

The high initial cost of implantable medical devices can be a deterrent for both patients and healthcare systems. Implantable medical devices frequently carry a hefty price tag that includes not only the cost of the device itself but also costs for the surgery, aftercare, and prospective device replacements or revisions in the future. However, these costs can be very expensive for many people, especially if they don't have proper health insurance or coverage. As a result, some patients could skip implantable treatments because they are unable to pay for them. The high cost of implantable medical devices is a significant barrier to market expansion.

Opportunity:

Increased prevalence of chronic diseases

Implantable medical devices are in high demand due to the increased prevalence of chronic diseases like diabetes, cardiovascular disease, and neurodegenerative disorders. These disorders can be managed and treated with the aid of devices like neuro stimulators, cardiac implants, and insulin pumps. Furthermore, implantable medical devices offer patients a higher quality of life and lessen the stress of ongoing care or frequent hospital visits by delivering a long-lasting and sustainable solution for controlling chronic disorders. These factors expand market demand.

Threat:

Device compatibility

As it might be difficult to make sure that implantable devices are properly integrated with a patient's individual anatomy and medical conditions, device compatibility is a significant barrier in the market for implantable medical devices. Each person has a unique anatomy and physiology. However, due to this variation, implanted medical technology must be customized to meet the unique requirements and traits of each patient. This problem is more obvious when gadgets need to be fitted specifically for a patient or when individualized treatment is needed. Therefore, it is a barrier to market demand.

COVID-19 Impact

The COVID-19 pandemic significantly slowed the industry's expansion as demand for implantable medical devices fell and all routine implantable surgeries were suspended in countries with the disease during the pandemic because of the high risk of cross-infection for medical personnel, auxiliaries, and patients undergoing implant procedures. The market for implantable medical devices has suffered as a result of the COVID-19 epidemic.

The metallic segment is expected to be the largest during the forecast period

The metallic segment is estimated to hold the largest share, due to both the expanding desire for minimally invasive surgeries among patients and the increasing number of traffic accidents and trauma cases around the world. Additionally, the rising use of metal implants in orthopaedic operations to offer sturdy support to broken bones or joints is responsible for this market's dominance. Therefore, this market is anticipated to continue expanding as more people throughout the world have arthritis.

The orthopaedic implants segment is expected to have the highest CAGR during the forecast period

The orthopaedic implants segment is anticipated to have lucrative growth during the forecast period. Orthopaedic implants are widely utilized around the world to support broken bones and replace missing bones or joints. The expansion of this market is being boosted by the increasing number of accidents that result in broken bones and damaged joints. Additionally, the prevalence of rheumatoid arthritis is increasing, leading to an increase in elbow joint replacement surgery. As a result, there are currently more orthopaedic procedures being performed, which could spur the development of orthopaedic implants in the years to come.

Region with largest share:

North America commanded the largest market share during the extrapolated period. Numerous chronic diseases are now more common in North America, and the number of elderly people is rising. Additionally, the availability of an advanced healthcare infrastructure, an increase in the use of minimally invasive procedures, and rising consumer healthcare spending are the key factors anticipated to propel the growth of the regional medical implant market. Furthermore, in the past, growing consumer awareness of the availability of different medical implants among North American residents has greatly aided market expansion.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, due to the expansion of the R&D industry, surge in healthcare reforms, improvement in healthcare infrastructure, increase in the number of hospitals with cutting-edge equipment, and technological developments in the field of implants. The vital role that medical devices play in the identification, monitoring and management of several illnesses contributes to an expanding need for them. The region is linked to a number of prominent medical equipment manufacturers and research centers.

Key players in the market:

Some of the key players in the Implantable Medical Devices Market include: Zimmer Biomet, Stryker, Dentsply Sirona, Terumo Corporation, Medtronic, Johnson & Johnson, Smith & Nephew, Danaher Corporation, Institut Straumann AG, Boston Scientific Corporation, Abbott, Alcon Laboratories, POLYTECH Health & Aesthetics, MicroPort Scientific Corporation, Bausch & Lomb, Cochlear Limited, Advanced Bionics Corporation and Henry Schein, Inc.

Key Developments:

In February 2022, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company's CardioMEMS HF System to support the care of more people living with heart failure.

In February 2022, Boston Scientific Corporation announced the completion of its purchase of Baylis Medical Company Inc., a provider of innovative transseptal access solutions as well as guide wires, sheaths, and dilators used in catheter-based left-heart surgeries.

Products Covered:

• Intraocular Lens
• Orthopaedic Implants
• Dental Implants
• Cardiovascular Implants
• Breast Implants
• Other Products

Types Covered:

• Diagnostic
• Treatment

Nature of Devices Covered:

• Non-active
• Active

Materials Covered:

• Cobalt Chromium Alloy
• Titanium Implants
• Stainless Steel
• Titanium Alloy
• Zirconium
• Polymers
• Biologics
• Metallic

End Users Covered:

• Hospitals
• Clinics
• Ambulatory Surgery Centers

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Implantable Medical Devices Market, By Product

• 5.1 Introduction
• 5.2 Intraocular Lens
• 5.3 Orthopedic Implants
  • 5.3.1 Trauma Fixation Devices
  • 5.3.2 Joint Reconstruction
  • 5.3.3 Spinal Devices
• 5.4 Dental Implants
  • 5.4.1 Dental Crowns & Abutment
• 5.5 Cardiovascular Implants
  • 5.5.1 Implantable Cardiac Defibrillators
  • 5.5.2 Pacemaker
  • 5.5.3 Stents
  • 5.5.4 Cardiac Resynchronization Therapy
  • 5.5.5 Ventricular Assist Devices
  • 5.5.6 Implantable Cardiac Monitors
• 5.6 Breast Implants
• 5.7 Other Products

6 Global Implantable Medical Devices Market, By Type

• 6.1 Introduction
• 6.2 Diagnostic
• 6.3 Treatment

7 Global Implantable Medical Devices Market, By Nature of Devices

• 7.1 Introduction
• 7.2 Non-active
• 7.3 Active

8 Global Implantable Medical Devices Market, By Material

• 8.1 Introduction
• 8.2 Cobalt Chromium Alloy
• 8.3 Titanium Implants
• 8.4 Stainless Steel
• 8.5 Titanium Alloy
• 8.6 Zirconium
• 8.7 Polymers
• 8.8 Biologics
• 8.9 Metallic

9 Global Implantable Medical Devices Market, By End User

• 9.1 Introduction
• 9.2 Hospitals
• 9.3 Clinics
• 9.4 Ambulatory Surgery Centers

10 Global Implantable Medical Devices Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Zimmer Biomet
• 12.2 Stryker
• 12.3 Dentsply Sirona
• 12.4 Terumo Corporation
• 12.5 Medtronic
• 12.6 Johnson & Johnson
• 12.7 Smith & Nephew
• 12.8 Danaher Corporation
• 12.9 Institut Straumann AG
• 12.10 Boston Scientific Corporation
• 12.11 Abbott
• 12.12 Alcon Laboratories
• 12.13 POLYTECH Health & Aesthetics
• 12.14 MicroPort Scientific Corporation
• 12.15 Bausch & Lomb
• 12.16 Cochlear Limited
• 12.17 Advanced Bionics Corporation
• 12.18 Henry Schein, Inc